Member Info for Pacman121

Please kindly cut and paste where I just said buy?

You're hatred is on autopilot. And I bet you still have the record number of posts for this board - spammer! zzzzZZZZZZZ

I'll look for your answer tomorrow. Try to remember which handle you're using, always used to make me smile when you got them confused. Nite Nite.

@Jace Where did I say buy? You are really really strange.

Quit attacking everyone with bu11****. Didn't even take you own advice to sell for the same months you mention despite claiming to know everything. You activey held a stock you knew was going to go down everyday until a placing killed it. Why did you do that? So strange.

Never called you a troll - you lie as much as Wallbrook. You are a spammer tho. Check the frequency of your own posts you complete loon - spammer 101. No one posts that often, well maybe your alias My luck.

UK government under pressure to use UK diagnostics after Innova scandal. Budd needs to stop messing about with the US. That had a catastrophic ending. Why can't you update the market with 'no sales', thats hardly a forward-looking statement is it?

Oh and the SP suppression on anything positive and Walbrooks complete failure to clarify anything - as mentioned the Indian regulation. 60% up in 2 hours followed by a really stupid RNS. Suspected as hell wasting time getting regulation in a country swamped with a horrible variation only to say, yea but we're a bit expensive for them. Nuts!

Don't get too involved with conspiracys and never bought into the buyout theory but am convinced the SP has been sabotaged based on being here almost a year.

Any idea on the takers? Will be interesting to see who appears on the shareholder list.

If AIHL and or POC get taken up then it's a go. I notice todays RNS has stated no prospectus for new investors - so just give us your money? Pretty sure the £6m party would have had an insight. Not sure which way PI's will go with this one. Many will want to average down and some take new positions. It did go pretty hard off the last placing and I still remember the resilliance the SP showed despite the heavy seller at the start of the year. Either way 24 million shares to churn through by October if we want to see a rise into Octobers launches. Both tests sound good, particularly like the AIHL, but deja vu anyone?

Guess it depends what sort of return the £6m club are looking for.

We know placing is out of the way.
We know they are creating products to keep the hefty paychecks coming in and have covered their salaries for another 2years if we take into account current cash.
We know they are vague with the truth.
We know that Walbrook lie.
We know AIHL and POC could be massive.
We know that AIHL is a world first and could be taken to UK (sites already in situ) and Europe fairly quickly.
We know FDA is slow as. Could it be faster for a world first or would they allow someone else to cashin on the idea while GDR is co{k blocked?
£17m must be tempting - but is it emperically?

Buy some stock and vote these guys out in Decembers AGM. Lets look for a results driven CEO, that entertains stakeholders and has skin in the game. Enough of these 3 month delay tactics.

AGM in December. Make sure you know how to vote them out by them.

@deerhunter. Yes mate, I think it's time for them to go. I do believe the products will come good hence the position but the etiquette of the board is too off point for me.

Inspiration health staff are liking all the posts on LinkedIn as are a bunch of others. Wouldn't surprise me if this goes pop, hence the increased position last week, but still unforgivable comms. Vote Board out in December's AGM.

Haha easy to spot isn't it.

While I don't appreciate the Boards attitude, AIHL has got a very decent professional following and has made a lot of noise over the last 3 years. Once CE hits (another 3 weeks or so based on approval timeframes), expect media coverage and so on. Weird they haven't shouted about it more but are we really surprised? Also the AIHL was part of a consortium so one cant be shouting louder than the other. It is a good test that is going to change the lives of the newborns as well as the families they are born into. Not much to say other than POC and AIHL deadlines have been drawn in the sand for 'The fall' - with early adopters for the AIHL on the buy button for commercial launch post the CE mark which is likely this month.

Happy to be called out but expect SP to move materially as we approach that milestone given what is now a very low MC. Developed and commercialised products add serious value which I think is what Budd is gunning for - and he can afford to be patient on his remuneration.

AGM approaches. Lets see if the CEO and CFO get re-elected (can't see either of them being popular with private investors who have been seriously shunted). Zero lip service amounts to zero votes in my experience, albeit institutions are also holding.

Everyone predicted a placing by now. There hasn't been one which suggests HCV sales (which we know are back on the table), and PCR sales are happening. Either way we'll have answers soon. Lots of interim results have come out for the last months for companies, showing financial to June. I'm guessing things have picked up since then given ordering cycles and the 360 report on the HCV sales.

Just checked CE marking takes on average 4 weeks. It can be sooner depending on results. We are making revisions based on competent person and expert feedback. Not sure if it can be moved up the paper pile but either way it's not a long process, unlike the FDA.

Early adopters have been implied so should hot the ground running. Most have been here ages and I think we all agree lack of Comms has been the most demoralising part of it. Things we should have been told that were put in publications rather than RNS's. David and Matt prob are getting things done but need to remember they are funded through AIM and adjust their attitudes accordingly.

Walbrook is a farce. They literally can't expand on a single detail when it comes to questions. Forget sales info etc, just a simple expansion on something I wouldnt understand not being a scientist. All you get is 'uodate when appropriate, fk off'. Wouldn't cry if they were voted out on sheer principle.

When's the next AGM?

Funded this consortium between GRR and some specialists to create the AIHL test. That's important to remember as it specifically happened to meet a very specific need. Same as the covid thing, just with no competition which makes it quite compelling in itself. NHS want it. Lots of experts following.

Agree Budd ould be more chatty and he is totally disrespectful toward shareholders. AIHL will be a success. The disappointment to date is understandable but we are at the very end of a 3 year trial and development cycle. This is the time to be in not out. For those of you a bit more seasoned on AIM if this was a company no one had heard of and all this was on the table sentiment would have it at a couple of quid. Negative sentiment can result in big wins. I jumped into metro Bank when everyone said it was going under then boom. That was basically done. This has multiple plus sides.

Why don't we all spend some time digging up clues on PCR sales, HCV sales and who's interested in the AIHL and report back. Let's just share info and keep off each others backs for a couple of days and make it a better place.

Happy weekend all (spammers included).

If needed place away I say. Let's get it done. Won't be that much anyway from this point. Avct placed, delivered flick all and directors cashed in and bought houses. I'd be up for that. On a side note is avct generating cash yet?

Said Walbrook to every request for information ever. Anna is blagging it to be honest.

Jace could you maybe spam her daily instead of us?

Yes. But the FREQUENCY. Come on its nuts.

Wrong chalice AHAHAHAHAHAHAHA! :D :D

@Franky phahahahahahaha! BRILLIANT!

@Rookie. I absolutely do get it mate. The difference with PCR (which may well be seeing some return-we just dont know) and AIHL is that the AIHL is a world-first so won't get drowned by any competition, or **** blocked by a Chinese influenced WHO and whatever is going on at the FDA (absolutely not cricket there).

AIHL 3 years in the making, successfully trialed and validated in the NHS and amendments to the tech to make it user-friendly for the NHS staff who will be using them. Lots of excitement. NHS will be adopting it. Don't forget this was also developed in a partnership. Not much noise around it but I expect that to change once the amendments have been CE marked.

The SP is down here for good reason, equally it can be higher for good reason. It's taken time but they've got it spot on.

Everyone predicted a placing by now. Like most of our guesses 100% of people were wrong on that one as well which implies revenues/profits are coming in. Think they're also getting another tax credit this year. Development costs are pretty much done. 2 products in final stages of commercial development for end of this month/ early Q4. SP goes ballistic when that happens to reflect value of commercialised products then contracts and a firm rerate. If you're comfortable in your position then you're comfortable waiting.

Boards are fairly quiet (save for spammers) but lots are here and lots are waiting. 1000+ trades on Indian approval news till Budd kicked it in the nuts after a 2 hour rally. It's tough but thats investing.

CE on the POC came fairly quickly. Can't see why it would be any different here especially as the original equipment was already CE markered and the changes for the AIHL are being done specifically on feedback from the NHS who obviously want the test. That should give it the SPa kick. Also the device was already listed on the PHE framework. This is a world-first and one that's needed today. Don't forget they saved hearing during the trial, everyday counts (like any decent test I guess). I agree SP is timid because of past false dawns but the test is complete, trials are complete and they are simply modifying the interfaces, bigger screen, a cartridge that goes click etc. PHE can stamp this one off quickly. 3 years of development concluded. https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2524